Article
Early response to selective serotonin reuptake inhibitors in panic disorder is associated with a functional 5-HT1A receptor gene polymorphism.
Journal of affective disorders - 1 Jun 2010
Yevtushenko Olga O, Oros Mykhaylo M, Reynolds Gavin P
Abstract excerpt
BACKGROUND: Panic disorder is a common and disabling condition which can be treated with selective serotonin reuptake inhibitors (SSRIs). Although many subjects respond well to such treatment, there is substantial inter-individual variation implicating genetic factors. METHODS: 102 patients with a diagnosis of panic disorder receiving sertraline or paroxetine took part in study. Hospital Anxiety and Depression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
